Broken String Biosciences appoints Steve Becker as Chief Commercial Officer

FHS
July 24, 2024
10:40 am

Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has appointed Steve Becker as Chief Commercial Officer.

Novartis teams up with Lindy Biosciences to improve biologic delivery – Pharmaceutical Technology

Novartis will gain exclusive access to the Lindy’s flagship microglassification technology. Credit: skynesher via Getty Images. Novartis has set its sights on the North Carolina

August 29, 2024

Researchers develop terahertz imaging systems for cancer detection

Medical imaging via X-rays, CT scans, MRIs and ultrasounds provide health-care professionals with unique perspectives and a better understanding of what’s happening inside a patient’s

August 14, 2023

Gene therapy offered this 7-year-old freedom. The price: a grueling year

PHILADELPHIA — The meds Shelby Campbell needed for her rare blood disorder stopped working just after her sixth birthday. She lost her appetite and was

December 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.